Coronavirus Update: After UK Nod, New Forecast Makes Pfizer Vaccine The Leader
Plus Russia Extends India Alliances
Executive Summary
After its historic first emergency approval, analysts at Bernstein has upgraded predictions for Pfizer/BioNTech's COVID-19 vaccine in 2021 and beyond.
You may also be interested in...
The Race To Develop A COVID-19 Vaccine: mRNA Pioneers Lead The Way
Our updated graphic tracker of key developments from the leading vaccine candidates.
UK Grants First Worldwide Authorization For Pfizer/BioNTech COVID-19 Vaccine
The UK's MHRA has granted an emergency authorization to the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
Moderna Files COVID-19 Vaccine After Second Impressive Read-Out
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
Need a specific report? 1000+ reports available
Buy Reports